| Therapy-related myeloid neoplasms: when genetics and environment collide ME McNerney, LA Godley, MM Le Beau Nature Reviews Cancer 17 (9), 513-527, 2017 | 347 | 2017 |
| A new self: MHC-class-I-independent natural-killer-cell self-tolerance V Kumar, ME McNerney Nature Reviews Immunology 5 (5), 363-374, 2005 | 272 | 2005 |
| 2B4 acts as a non–major histocompatibility complex binding inhibitory receptor on mouse natural killer cells KM Lee, ME McNerney, SE Stepp, PA Mathew, JD Schatzle, M Bennett, ... The Journal of experimental medicine 199 (9), 1245-1254, 2004 | 239 | 2004 |
| CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia ME McNerney, CD Brown, X Wang, ET Bartom, S Karmakar, ... Blood, The Journal of the American Society of Hematology 121 (6), 975-983, 2013 | 179 | 2013 |
| Role of natural killer cell subsets in cardiac allograft rejection ME McNerney, KM Lee, P Zhou, L Molinero, M Mashayekhi, D Guzior, ... American journal of transplantation 6 (3), 505-513, 2006 | 156 | 2006 |
| 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells ME McNerney, KM Lee, V Kumar Molecular immunology 42 (4), 489-494, 2005 | 129 | 2005 |
| Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells SV Vaidya, SE Stepp, ME McNerney, JK Lee, M Bennett, KM Lee, ... The Journal of Immunology 174 (2), 800-807, 2005 | 122 | 2005 |
| Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays S Kadri, BC Long, I Mujacic, CJ Zhen, MN Wurst, S Sharma, N McDonald, ... The Journal of Molecular Diagnostics 19 (1), 43-56, 2017 | 119 | 2017 |
| Requirement of homotypic NK-cell interactions through 2B4 (CD244)/CD48 in the generation of NK effector functions KM Lee, JP Forman, ME McNerney, S Stepp, S Kuppireddi, D Guzior, ... Blood 107 (8), 3181-3188, 2006 | 114 | 2006 |
| Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells Y Yi, M McNerney, SK Datta The Journal of Immunology 165 (11), 6627-6634, 2000 | 111 | 2000 |
| Bionimbus: a cloud for managing, analyzing and sharing large genomics datasets AP Heath, M Greenway, R Powell, J Spring, R Suarez, D Hanley, ... Journal of the American Medical Informatics Association 21 (6), 969-975, 2014 | 100 | 2014 |
| Widespread genetic epistasis among cancer genes X Wang, AQ Fu, ME McNerney, KP White Nature communications 5 (1), 4828, 2014 | 82 | 2014 |
| Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in Nras-Driven Hematopoietic Transformation J Xu, KM Haigis, AJ Firestone, ME McNerney, Q Li, E Davis, SC Chen, ... Cancer discovery 3 (9), 993-1001, 2013 | 70 | 2013 |
| 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK-cell self-tolerance in mice ME McNerney, D Guzior, V Kumar Blood 106 (4), 1337-1340, 2005 | 70 | 2005 |
| Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression TP Stricker, CD Brown, C Bandlamudi, M McNerney, R Kittler, V Montoya, ... PLoS genetics 13 (3), e1006589, 2017 | 67 | 2017 |
| Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA J Brägelmann, I Dagogo-Jack, M El Dinali, T Stricker, CD Brown, Z Zuo, ... Oral oncology 49 (6), 525-533, 2013 | 57 | 2013 |
| Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS N An, S Khan, MK Imgruet, SK Gurbuxani, SN Konecki, MR Burgess, ... Blood, The Journal of the American Society of Hematology 131 (24), 2682-2697, 2018 | 50 | 2018 |
| Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis Z Zhao, CC Chen, CD Rillahan, R Shen, T Kitzing, ME McNerney, ... Nature genetics 47 (5), 539-543, 2015 | 49 | 2015 |
| The CD2 family of natural killer cell receptors ME McNerney, V Kumar Immunobiology of Natural Killer Cell Receptors, 91-120, 2006 | 42 | 2006 |
| Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor DJ Voce, AM Schmitt, A Uppal, ME McNerney, GM Bernal, KE Cahill, ... Oncogene 34 (21), 2807-2813, 2015 | 39 | 2015 |
Christopher D BrownAssociate Professor of Genetics, University of Pennsylvania在 pennmedicine.upenn.edu 的电子邮件经过验证
